Trial intelligence / Profile preview

Phase II double-blind study of HR18042 tablets for pain after impacted tooth extraction

CTR20202284Phase 2Completed

Sponsor
Chengdu Shengdi
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of HR18042 in acute pain, sponsored by Chengdu Shengdi. Started Dec 2020; status: completed.

02

Drugs

HR18042
03

Conditions

acute pain

Beyond the preview

Go deeper on CTR20202284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20202284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call